N'-HydroxyiMidoforMaMide is used in biochemical and pharmacological research to investigate the mechanisms of enzyme inhibition, particularly enzymes involved in cancer cell metabolism. It is being studied for its potential as an anticancer agent, focusing on inhibiting cancer cell growth and inducing programmed cell death (apoptosis). These investigations are still in the experimental stage, requiring further studies to confirm efficacy and safety before potential clinical application in cancer therapy, especially for treatment-resistant cancers. Research also explores its ability to enhance combination therapies and selectively target diseased cells to minimize side effects.